Literature DB >> 32320084

Response to Char's comment: Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.

Long-Quan Li1,2,3, Tian Huang1,2,3, Yong-Qing Wang4, Zheng-Ping Wang5, Yuan Liang1,2,3, Tao-Bi Huang1,2,3, Hui-Yun Zhang1,2,3, Wei-Ming Sun6, Yu-Ping Wang2,3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32320084      PMCID: PMC7264725          DOI: 10.1002/jmv.25924

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


× No keyword cloud information.
To the Editor, We have read Leung's comment. Thanks for readers' attention and valuable feedback on our article. Following was our response to Leung's question about data overlap. First, the meta‐analysis reprocessed the existing data about patients with COVID‐19 in published articles and involved no other information outside of the article. Second, each patients' regions, hospitals, departments, time periods of when they hospitalized, and other detailed information can be precisely distinguished only when the original data were obtained. Thus, whether data overlap existed was still uncertain. We contacted the corresponding authors to obtain the original data, but we have not received a reply yet. Finally, we agree that readers are advised to interpret the results with caution. When we acquire original data, we will reprocess data to make sure if data overlap existed and if necessarily, we will provide the finally revision of our study publicly.

CONFLICT OF INTERESTS

All the authors declare that there are no conflict of interests.
  2 in total

1.  Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.

Authors:  Char Leung
Journal:  J Med Virol       Date:  2020-06-12       Impact factor: 2.327

Review 2.  COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.

Authors:  Long-Quan Li; Tian Huang; Yong-Qing Wang; Zheng-Ping Wang; Yuan Liang; Tao-Bi Huang; Hui-Yun Zhang; Weiming Sun; Yuping Wang
Journal:  J Med Virol       Date:  2020-03-23       Impact factor: 2.327

  2 in total
  5 in total

1.  Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews.

Authors:  Israel Júnior Borges do Nascimento; Dónal P O'Mathúna; Thilo Caspar von Groote; Hebatullah Mohamed Abdulazeem; Ishanka Weerasekara; Ana Marusic; Livia Puljak; Vinicius Tassoni Civile; Irena Zakarija-Grkovic; Tina Poklepovic Pericic; Alvaro Nagib Atallah; Santino Filoso; Nicola Luigi Bragazzi; Milena Soriano Marcolino
Journal:  BMC Infect Dis       Date:  2021-06-04       Impact factor: 3.090

Review 2.  Male bias in ACE2 basic science research: missed opportunity for discovery in the time of COVID-19.

Authors:  Branka Miličić Stanić; Sydney Maddox; Aline M A de Souza; Xie Wu; Danial Mehranfard; Hong Ji; Robert C Speth; Kathryn Sandberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-13       Impact factor: 3.210

3.  Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis.

Authors:  Xiaobo He; Xiao Cheng; Xudong Feng; Hong Wan; Sihan Chen; Maoming Xiong
Journal:  Front Public Health       Date:  2021-01-14

Review 4.  Herbal Medicine, Gut Microbiota, and COVID-19.

Authors:  Ziqi Chen; Yiwen Lv; Huachong Xu; Li Deng
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.988

5.  Clinical characteristics and prognostic factors of COVID-19 patients progression to severe: a retrospective, observational study.

Authors:  Yunfei Liao; Yong Feng; Bo Wang; Hanyu Wang; Jinsha Huang; Yaxin Wu; Ziling Wu; Xiao Chen; Chao Yang; Xinqiao Fu; Hui Sun
Journal:  Aging (Albany NY)       Date:  2020-10-14       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.